1260177993026211840

Today at 8:30 a.m. ET we will hold a conference call to review the positive topline results from the global, randomized Phase 3 study of our investigational advanced cell therapy, omidubicel. See our press release for instructions on accessing our webcast: https://t.co/TljfowjTOD

Send us a message